Sleep Disorders and Cardiometabolic Health

Sleep disorders significantly influence cardiometabolic health, linking poor sleep to conditions such as hypertension, obesity, type 2 diabetes, and heart disease. Disrupted sleep patterns, including sleep apnea and insomnia, can alter metabolic function, elevate stress hormones, and increase inflammation. These physiological changes place extra strain on the cardiovascular system, impair glucose regulation, and disrupt lipid metabolism. Early detection and proper management of sleep-related issues are essential to support overall metabolic balance and reduce long-term health risks. Promoting restorative sleep through behavioral interventions, lifestyle adjustments, and targeted therapies can play a vital role in maintaining heart and metabolic system resilience.

    Related Conference of Sleep Disorders and Cardiometabolic Health

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Sleep Disorders and Cardiometabolic Health Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in